🇺🇸 FDA
Pipeline program

bupropion SR

K23DA000510

Approved small_molecule completed

Quick answer

bupropion SR for Tobacco-Use Disorder is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tobacco-Use Disorder
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials